Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ZYNE Zynerba Pharmaceuticals Inc

1,30

0,00 (0,00%)

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Zynerba Pharmaceuticals Charts.

Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Zynerba Pharmaceuticals Charts.

News Zynerba Pharmaceuticals Inc

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Freitag 9 Februar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Donnerstag 19 Oktober 2023 (8 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 12 Oktober 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 11 Oktober 2023 (9 Monate vor) • Edgar (US Regulatory)

Weitere Zynerba Pharmaceuticals Inc News-Artikel

Teleperformance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen